Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2003 | 1 |
2007 | 1 |
2008 | 2 |
2011 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Trace Amine-Associated Receptor 1 Contributes to Diverse Functional Actions of O-Phenyl-Iodotyramine in Mice but Not to the Effects of Monoamine-Based Antidepressants.
Int J Mol Sci. 2021 Aug 18;22(16):8907. doi: 10.3390/ijms22168907.
Int J Mol Sci. 2021.
PMID: 34445611
Free PMC article.
Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents.
Brocco M, Dekeyne A, Mannoury la Cour C, Touzard M, Girardon S, Veiga S, de Nanteuil G, deJong TR, Olivier B, Millan MJ.
Brocco M, et al. Among authors: veiga s.
Eur Neuropsychopharmacol. 2008 Oct;18(10):729-50. doi: 10.1016/j.euroneuro.2008.06.002. Epub 2008 Jul 26.
Eur Neuropsychopharmacol. 2008.
PMID: 18657401
Item in Clipboard
Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA).
Di Cara B, Maggio R, Aloisi G, Rivet JM, Lundius EG, Yoshitake T, Svenningsson P, Brocco M, Gobert A, De Groote L, Cistarelli L, Veiga S, De Montrion C, Rodriguez M, Galizzi JP, Lockhart BP, Cogé F, Boutin JA, Vayer P, Verdouw PM, Groenink L, Millan MJ.
Di Cara B, et al. Among authors: veiga s.
J Neurosci. 2011 Nov 23;31(47):16928-40. doi: 10.1523/JNEUROSCI.2502-11.2011.
J Neurosci. 2011.
PMID: 22114263
Free PMC article.
Item in Clipboard
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
Millan MJ, Svenningsson P, Ashby CR Jr, Hill M, Egeland M, Dekeyne A, Brocco M, Di Cara B, Lejeune F, Thomasson N, Munoz C, Mocaër E, Crossman A, Cistarelli L, Girardon S, Iob L, Veiga S, Gobert A.
Millan MJ, et al. Among authors: veiga s.
J Pharmacol Exp Ther. 2008 Feb;324(2):600-11. doi: 10.1124/jpet.107.132563. Epub 2007 Nov 16.
J Pharmacol Exp Ther. 2008.
PMID: 18024787
Item in Clipboard
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
Brocco M, Dekeyne A, Veiga S, Girardon S, Millan MJ.
Brocco M, et al. Among authors: veiga s.
Pharmacol Biochem Behav. 2002 Apr;71(4):667-80. doi: 10.1016/s0091-3057(01)00701-8.
Pharmacol Biochem Behav. 2002.
PMID: 11888558
Item in Clipboard
Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
Millan MJ, Veiga S, Girardon S, Brocco M.
Millan MJ, et al. Among authors: veiga s.
Psychopharmacology (Berl). 2003 Aug;168(4):397-409. doi: 10.1007/s00213-003-1389-y. Epub 2003 Apr 30.
Psychopharmacology (Berl). 2003.
PMID: 12721776
Item in Clipboard
Cite
Cite